Israel Englander Amgen Inc Call Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $19.6 Million - $21.4 Million	-63,400 Reduced 18.18%	285,300 $91.9 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $29.9 Million - $36.3 Million	113,700 Added 48.38%	348,700 $109 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $44.7 Million - $54 Million	-166,300 Reduced 41.44%	235,000 $66.8 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $67.1 Million - $75.7 Million	-262,500 Reduced 39.55%	401,300 $116 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $34.9 Million - $41.3 Million	163,100 Added 32.57%	663,800 $147 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $17.6 Million - $21.5 Million	-78,000 Reduced 13.48%	500,700 $121 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $2.75 Million - $3.49 Million	-12,000 Reduced 2.03%	578,700 $152 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $46.2 Million - $52.1 Million	206,000 Added 53.55%	590,700 $133 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.